Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03564691
Title Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of California at San Francisco ( Site 0004) San Francisco California 94158 United States Details
Henry Ford Health System ( Site 0002) Detroit Michigan 48202 United States Details
Washington University ( Site 0003) Saint Louis Missouri 63110 United States Details
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005) Hackensack New Jersey 07601 United States Details
Laura and Isaac Perlmutter Cancer Center ( Site 0008) New York New York 10016 United States Details
Ohio State University Arthur G James Cancer Hospital & Richard J Solove Research Institute ( Site 00 Columbus Ohio 43210 United States Details
South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001) San Antonio Texas 78229 United States Details
Utah Cancer Specialists ( Site 0011) Salt Lake City Utah 84106 United States Details
Seattle Cancer Care Alliance ( Site 0010) Seattle Washington 98109 United States Details
Liverpool Hospital-Medical Oncology ( Site 0250) Liverpool New South Wales 2170 Australia Details
Princess Alexandra Hospital ( Site 0253) Brisbane Queensland 4102 Australia Details
Juravinski Cancer Centre ( Site 0034) Hamilton Ontario L8V 5C2 Canada Details
The Ottawa Hospital ( Site 0031) Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Centre ( Site 0033) Toronto Ontario M5G 2M9 Canada Details
The First Hospital of Jilin University ( Site 0803) Changchun Jilin 130021 China Details
Shanghai Chest Hospital-Oncology department ( Site 0801) Shanghai Shanghai 200030 China Details
West China Hospital of Sichuan University ( Site 0804) Chengdu Sichuan 610041 China Details
Hôpital Européen Georges Pompidou ( Site 2003) Paris Ile-de-France 75015 France Details
Centre Oscar Lambret ( Site 2002) Lille Nord 59000 France Details
Centre Hospitalier Universitaire de Poitiers ( Site 2000) Poitiers Vienne 86000 France Details
University General Hospital of Heraklion ( Site 0110) Heraklion Irakleio 711 10 Greece Details
Euromedica General Clinic of Thessaloniki-Oncology Unit ( Site 0112) Thessaloniki 546 45 Greece Details
European Interbalkan Medical Center ( Site 0111) Thessaloniki 57001 Greece Details
Rambam Health Care Campus-Oncology Division ( Site 0042) Haifa 3109601 Israel Details
Rabin Medical Center ( Site 0043) Petah Tikva 4941492 Israel Details
Chaim Sheba Medical Center. ( Site 0044) Ramat Gan 5265601 Israel Details
Sourasky Medical Center ( Site 0041) Tel Aviv 6423906 Israel Details
National Cancer Center Hospital East ( Site 0400) Kashiwa Chiba 2778577 Japan Details
Japanese Foundation for Cancer Research ( Site 0401) Tokyo 135-8550 Japan Details
Severance Hospital Yonsei University Health System ( Site 0300) Seoul 03722 Korea, Republic of Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Warszawa Mazowieckie 02-781 Poland Details
Uniwersyteckie Centrum Kliniczne ( Site 0151) Gdansk Pomorskie 80-214 Poland Details
Wits Clinical Research ( Site 0213) Johannesburg Gauteng 2193 South Africa Details
The Oncology Centre ( Site 0212) Durban Kwazulu-Natal 4091 South Africa Details
Cancercare Rondebosch Oncology ( Site 0210) Cape Town Western Cape 7700 South Africa Details
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0101) Hospitalet de Llobregat Barcelona 08908 Spain Details
Centro Integral Oncologico Clara Campal START Madrid ( Site 0102) Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field